CFGS
Concourse Financial Group Securities’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-710
| Closed | -$96.8K | – | 3801 |
|
2024
Q4 | $96.8K | Buy |
710
+49
| +7% | +$6.68K | 0.01% | 957 |
|
2024
Q3 | $96.2K | Buy |
661
+5
| +0.8% | +$728 | 0.01% | 947 |
|
2024
Q2 | $90K | Buy |
656
+120
| +22% | +$16.5K | 0.01% | 962 |
|
2024
Q1 | $73.5K | Sell |
536
-34
| -6% | -$4.67K | ﹤0.01% | 1029 |
|
2023
Q4 | $77.4K | Sell |
570
-13
| -2% | -$1.77K | 0.01% | 981 |
|
2023
Q3 | $71.4K | Sell |
583
-85
| -13% | -$10.4K | 0.01% | 955 |
|
2023
Q2 | $84.8K | Sell |
668
-123
| -16% | -$15.6K | 0.01% | 910 |
|
2023
Q1 | $102K | Sell |
791
-25
| -3% | -$3.23K | 0.01% | 862 |
|
2022
Q4 | $107K | Sell |
816
-20
| -2% | -$2.63K | 0.01% | 818 |
|
2022
Q3 | $98K | Sell |
836
-256
| -23% | -$30K | 0.01% | 726 |
|
2022
Q2 | $128K | Sell |
1,092
-168
| -13% | -$19.7K | 0.01% | 722 |
|
2022
Q1 | $164K | Sell |
1,260
-578
| -31% | -$75.2K | 0.01% | 701 |
|
2021
Q4 | $281K | Buy |
1,838
+113
| +7% | +$17.3K | 0.02% | 616 |
|
2021
Q3 | $279K | Buy |
1,725
+41
| +2% | +$6.63K | 0.02% | 607 |
|
2021
Q2 | $276K | Sell |
1,684
-787
| -32% | -$129K | 0.02% | 623 |
|
2021
Q1 | $372K | Sell |
2,471
-50,853
| -95% | -$7.66M | 0.03% | 482 |
|
2020
Q4 | $8.08M | Sell |
53,324
-27,731
| -34% | -$4.2M | 0.61% | 34 |
|
2020
Q3 | $11M | Buy |
81,055
+23,945
| +42% | +$3.24M | 0.96% | 21 |
|
2020
Q2 | $7.81M | Buy |
57,110
+53,004
| +1,291% | +$7.24M | 0.76% | 30 |
|
2020
Q1 | $442K | Buy |
4,106
+311
| +8% | +$33.5K | 0.05% | 272 |
|
2019
Q4 | $457K | Buy |
3,795
+1,974
| +108% | +$238K | 0.05% | 312 |
|
2019
Q3 | $182K | Sell |
1,821
-1,947
| -52% | -$195K | 0.05% | 310 |
|
2019
Q2 | $411K | Buy |
3,768
+133
| +4% | +$14.5K | 0.04% | 300 |
|
2019
Q1 | $406K | Buy |
3,635
+2,304
| +173% | +$257K | 0.04% | 306 |
|
2018
Q4 | $128K | Sell |
1,331
-5,583
| -81% | -$537K | 0.02% | 563 |
|
2018
Q3 | $843K | Buy |
+6,914
| New | +$843K | 0.24% | 91 |
|